Increased CD45 expression in the inhibitor group (as compared to controls) at 14 days after stroke may be associated with prolonged upregulation of IL-10, since IL-10 was found to activate CD45 protein tyrosine phosphatase [65]. The gene discussed is PTPRC; the disease is stroke disorder.